Home / Latest Reports / Genital Herpes Treatment Market

Genital Herpes Treatment Market By Drug Type, Indication, Route of Administration and Distribution Channel - Global Industry Analysis And Forecast To 2027

Published On : December 2018 Pages : 180 Category: Medical Devices Report Code : HC122201

Request Sample Inquiry Before Buying Request for Customization Check Discount

Genital Herpes Treatment Market By Drug Type (Famciclovir, Acyclovir and Valacyclovir); Indication (HSV-1 and HSV-2); Route of Administration (Injectable, Oral and Topical); and Distribution Channel (Drug Stores, Hospital Pharmacies, Online Pharmacies and Retail Pharmacies); - Global Industry Analysis And Forecast To 2027

Industry Outlook

Genital Herpes is a Sexually transmitted Disease (STD). Genital Herpes causes herpetic inflammation, which have painful blisters (liquid-filled bumps) that can open and let the fluid flow. Genital Herpes is caused by two types of Herpes Simplex Virus; HSV-1 (which causes cold sores) and HSV-2 (which causes genital herpes). These virus enter human body through mucous membranes, which are thin layers of tissues lining opening of body found in nose, mouth and genitals. Some common indications of Genital Herpes are; blisters in or around genitals, vaginal discharge, penile discharge and pelvic pain. Some factors for rise in Genital Herpes Treatment are; rising requirement for effective therapy for treatment, government initiative across the globe to spread awareness among people about STD, many organizations and industries are coming together to find a effective therapy, etc. Therefore, the Genital Herpes Treatment Market is anticipated to expand and has tremendous scope during the forecast period. The global Genital Herpes Treatment Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Genital Herpes Treatment Market is based on segment, by Drug Type the market is segmented into Famciclovir, Acyclovir and Valacyclovir; by Indication the market is segmented into HSV-1 and HSV-2; by Route of Administration the market is segmented into Injectable, Oral and Topical; and by Distribution Channel the market is segmented into Drug Stores, Hospital Pharmacies, Online Pharmacies and Retail Pharmacies.

  • Genital Herpes Treatment Market, By Drug Type
  • Famciclovir
  • Acyclovir
  • Valacyclovir
  • Genital Herpes Treatment Market, By Indication
  • HSV-1
  • HSV-2
  • Genital Herpes Treatment Market, By Route of Administration
  • Injectable
  • Oral
  • Topical
  • Genital Herpes Treatment Market, By Distribution Channel
  • Drug Stores
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regional Insights

On a global front, the Genital Herpes Treatment Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Genital Herpes Treatment Market, followed by European region, due to developed healthcare sector and growing awareness in the population about sexually transmitted diseases/infections.

Genital Herpes Treatment Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Dr. Reddy’s Laboratories Ltd., Mylan Pharmaceuticals Inc., Teva Pharmaceuticals Inc., Novartis AG, Hospira Inc., Sandoz Inc., Novopharm Ltd., Apotheca Inc., and GlaxoSmithKline. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Dr. Reddy’s Laboratories Ltd.
  • Mylan Pharmaceuticals Inc.
  • Teva Pharmaceuticals Inc.
  • Novartis AG
  • Hospira Inc.
  • Sandoz Inc.
  • Novopharm Ltd.
  • Apotheca Inc.
  • GlaxoSmithKline

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Genital Herpes Treatment Market, By Drug Type, Estimates and Forecast, 2017-2027 ($Million)

o   Famciclovir

o   Acyclovir

o   Valacyclovir

o   Genital Herpes Treatment Market, By Indication, Estimates and Forecast, 2017-2027 ($Million)

o   HSV-1

o   HSV-2

o   Genital Herpes Treatment Market, By Route of Administration, Estimates and Forecast, 2017-2027 ($Million)

o   Injectable

o   Oral

o   Topical

o   Genital Herpes Treatment Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)

o   Drug Stores

o   Hospital Pharmacies

o   Online Pharmacies

o   Retail Pharmacies

o   Genital Herpes Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Genital Herpes Treatment Market, By Country

o   U.S. Genital Herpes Treatment Market

o   Canada Genital Herpes Treatment Market

o   Mexico Genital Herpes Treatment Market

o   Europe

§  Europe Genital Herpes Treatment Market, By Country

o   Germany Genital Herpes Treatment Market

o   UK Genital Herpes Treatment Market

o   France Genital Herpes Treatment Market

o   Russia Genital Herpes Treatment Market

o   Italy Genital Herpes Treatment Market

o   Rest of Europe Genital Herpes Treatment Market

o   Asia-Pacific

§  Asia-Pacific Genital Herpes Treatment Market, By Country

o   China Genital Herpes Treatment Market

o   Japan Genital Herpes Treatment Market

o   South Korea  Genital Herpes Treatment Market

o   India Genital Herpes Treatment Market

o   Southeast Asia Genital Herpes Treatment Market

o   Rest of Asia-Pacific Genital Herpes Treatment Market

o   South America

§  South America Genital Herpes Treatment Market, By Country

o   Brazil Genital Herpes Treatment Market

o   Argentina Genital Herpes Treatment Market

o   Columbia Genital Herpes Treatment Market

o   Rest of South America Genital Herpes Treatment Market

o   Middle East and Africa

§  Middle East and Africa Genital Herpes Treatment Market, By Country

o   Saudi Arabia Genital Herpes Treatment Market

o   UAE Genital Herpes Treatment Market

o   Egypt Genital Herpes Treatment Market

o   Nigeria Genital Herpes Treatment Market

o   South Africa Genital Herpes Treatment Market

o   Rest of MEA Genital Herpes Treatment Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Genital Herpes Treatment Market, By Type

5.1.     Introduction

5.2.     Global Genital Herpes Treatment Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Genital Herpes Treatment Revenue and Revenue Share by Type (2017-2027)

5.3.     Famciclovir

5.3.1.  Global Famciclovir Revenue and Growth Rate (2017-2027)

5.4.     Acyclovir

5.4.1.  Global Acyclovir Revenue and Growth Rate (2017-2027)

5.5.     Valacyclovir

5.5.1.  Global Valacyclovir Revenue and Growth Rate (2017-2027)

6.       Genital Herpes Treatment Market, By Indication

6.1.     Introduction

6.2.     Global Genital Herpes Treatment Revenue and Market Share by Indication (2017-2027)

6.2.1.  Global Genital Herpes Treatment Revenue and Revenue Share by Indication (2017-2027)

6.3.     HSV-1

6.3.1.  Global HSV-1 Revenue and Growth Rate (2017-2027)

6.4.     HSV-2

6.4.1.  Global HSV-2 Revenue and Growth Rate (2017-2027)

7.       Genital Herpes Treatment Market, By Route Of Administration

7.1.     Introduction

7.2.     Global Genital Herpes Treatment Revenue and Market Share by Route Of Administration (2017-2027)

7.2.1.  Global Genital Herpes Treatment Revenue and Revenue Share by Route Of Administration (2017-2027)

7.3.     Injectable

7.3.1.  Global Injectable Revenue and Growth Rate (2017-2027)

7.4.     Oral

7.4.1.  Global Oral Revenue and Growth Rate (2017-2027)

7.5.     Topical

7.5.1.  Global Topical Revenue and Growth Rate (2017-2027)

8.       Genital Herpes Treatment Market, By Distribution Channel

8.1.     Introduction

8.2.     Global Genital Herpes Treatment Revenue and Market Share by Distribution Channel (2017-2027)

8.2.1.  Global Genital Herpes Treatment Revenue and Revenue Share by Distribution Channel (2017-2027)

8.3.     Drug Stores

8.3.1.  Global Drug Stores Revenue and Growth Rate (2017-2027)

8.4.     Hospital Pharmacies

8.4.1.  Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)

8.5.     Online Pharmacies

8.5.1.  Global Online Pharmacies Revenue and Growth Rate (2017-2027)

8.6.     Retail Pharmacies

8.6.1.  Global Retail Pharmacies Revenue and Growth Rate (2017-2027)

9.       Genital Herpes Treatment Market, By Region

9.1.     Introduction

9.2.     Global Genital Herpes Treatment Revenue and Market Share by Regions

9.2.1.  Global Genital Herpes Treatment Revenue by Regions (2017-2027)

9.3.     North America Genital Herpes Treatment by Countries

9.3.1.  North America Genital Herpes Treatment Revenue and Growth Rate (2017-2027)

9.3.2.  North America Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Genital Herpes Treatment by Countries

9.4.1.  Europe Genital Herpes Treatment Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Genital Herpes Treatment by Countries

9.5.1.  Asia-Pacific Genital Herpes Treatment Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Genital Herpes Treatment by Countries

9.6.1.  South America Genital Herpes Treatment Revenue and Growth Rate (2017-2027)

9.6.2.  South America Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Genital Herpes Treatment by Countries

9.7.1.  Middle East and Africa Genital Herpes Treatment Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. Dr. Reddy’s Laboratories Ltd.

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. Mylan Pharmaceuticals Inc.

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Teva Pharmaceuticals Inc.

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. Novartis AG

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. Hospira Inc.

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Sandoz Inc.

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. Novopharm Ltd.

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. Apotheca Inc.

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. GlaxoSmithKline

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

11.    Global Genital Herpes Treatment Market Competition, by Manufacturer

11.1. Global Genital Herpes Treatment Revenue and Market Share by Manufacturer (2017-2017)

11.2. Top 5 Genital Herpes Treatment Manufacturer Market Share

11.3. Market Competition Trend

12.    Genital Herpes Treatment Market Forecast (2017-2027)

12.1. Global Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Genital Herpes Treatment Market Forecast by Regions (2017-2027)

12.2.1.      North America Genital Herpes Treatment Market Forecast (2017-2027)

12.2.1.1. United States Genital Herpes Treatment Market Forecast (2017-2027)

12.2.1.2. Canada Genital Herpes Treatment Market Forecast (2017-2027)

12.2.1.3. Mexico Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.      Europe Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.1. Germany Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.2. France Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.3. UK Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.4. Russia Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.5. Italy Genital Herpes Treatment Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.1. China Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.2. Japan Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.3. Korea Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.4. India Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Genital Herpes Treatment Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Genital Herpes Treatment Market Forecast (2017-2027)

12.2.4.      South America Genital Herpes Treatment Market Forecast (2017-2027)

12.2.4.1. Brazil Genital Herpes Treatment Market Forecast (2017-2027)

12.2.4.2. Argentina Genital Herpes Treatment Market Forecast (2017-2027)

12.2.4.3. Columbia Genital Herpes Treatment Market Forecast (2017-2027)

12.2.4.4. Rest of South America Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.3. Egypt Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.4. Nigeria Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.5. South Africa Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.6. Turkey Genital Herpes Treatment Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Genital Herpes Treatment Market Forecast (2017-2027)

12.3. Genital Herpes Treatment Market Forecast by Type (2017-2027)

12.3.1.      Genital Herpes Treatment Forecast by Type (2017-2027)

12.3.2.      Genital Herpes Treatment Market Share Forecast by Type (2017-2027)

12.4. Genital Herpes Treatment Market Forecast by Indication (2017-2027)

12.4.1.      Genital Herpes Treatment Forecast by Indication (2017-2027)

12.4.2.      Genital Herpes Treatment Market Share Forecast by Indication (2017-2027)

12.5. Genital Herpes Treatment Market Forecast by Route Of Administration (2017-2027)

12.5.1.      Genital Herpes Treatment Forecast by Route Of Administration (2017-2027)

12.5.2.      Genital Herpes Treatment Market Share Forecast by Route Of Administration (2017-2027)

12.6. Genital Herpes Treatment Market Forecast by Distribution Channel (2017-2027)

12.6.1.      Genital Herpes Treatment Forecast by Distribution Channel (2017-2027)

12.6.2.      Genital Herpes Treatment Market Share Forecast by Distribution Channel (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Genital Herpes Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Genital Herpes Treatment Revenue and Revenue Share by Type (2017-2018)
Figure Global Famciclovir Revenue and Growth Rate (2017-2018)
Figure Global Acyclovir Revenue and Growth Rate (2017-2018)
Figure Global Valacyclovir Revenue and Growth Rate (2017-2018)
Table Global Genital Herpes Treatment Revenue and Revenue Share by Indication (2017-2018)
Figure Global HSV-1 Revenue and Growth Rate (2017-2018)
Figure Global HSV-2 Revenue and Growth Rate (2017-2018)
Table Global Genital Herpes Treatment Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Injectable Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Figure Global Topical Revenue and Growth Rate (2017-2018)
Table Global Genital Herpes Treatment Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Drug Stores Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Genital Herpes Treatment Revenue by Regions (2017-2018)
Figure North America Genital Herpes Treatment Growth Rate (2017-2018)
Figure North America Genital Herpes Treatment Revenue and Growth Rate (2017-2018)
Figure North America Genital Herpes Treatment by Countries (2017-2018)
Figure North America Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Genital Herpes Treatment Growth Rate (2017-2018)
Figure United States Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Genital Herpes Treatment Growth Rate (2017-2018)
Figure Canada Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Genital Herpes Treatment Growth Rate (2017-2018)
Figure Mexico Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Genital Herpes Treatment Growth Rate (2017-2018)
Figure Europe Genital Herpes Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Genital Herpes Treatment by Countries (2017-2018)
Figure Europe Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Genital Herpes Treatment Growth Rate (2017-2018)
Figure Germany Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Genital Herpes Treatment Growth Rate (2017-2018)
Figure France Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Genital Herpes Treatment Growth Rate (2017-2018)
Figure UK Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Genital Herpes Treatment Growth Rate (2017-2018)
Figure Russia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Genital Herpes Treatment Growth Rate (2017-2018)
Figure Italy Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Genital Herpes Treatment Growth Rate (2017-2018)
Figure Rest of Europe Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Genital Herpes Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Genital Herpes Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Genital Herpes Treatment by Countries (2017-2018)
Figure Asia-Pacific Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Genital Herpes Treatment Growth Rate (2017-2018)
Figure China Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Genital Herpes Treatment Growth Rate (2017-2018)
Figure Japan Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Genital Herpes Treatment Growth Rate (2017-2018)
Figure Korea Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Genital Herpes Treatment Growth Rate (2017-2018)
Figure India Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Genital Herpes Treatment Growth Rate (2017-2018)
Figure Southeast Asia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Genital Herpes Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Genital Herpes Treatment Growth Rate (2017-2018)
Figure South America Genital Herpes Treatment Revenue and Growth Rate (2017-2018)
Figure South America Genital Herpes Treatment by Countries (2017-2018)
Figure South America Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Genital Herpes Treatment Growth Rate (2017-2018)
Figure Brazil Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Genital Herpes Treatment Growth Rate (2017-2018)
Figure Argentina Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Genital Herpes Treatment Growth Rate (2017-2018)
Figure Columbia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Genital Herpes Treatment Growth Rate (2017-2018)
Figure Rest of South America Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Genital Herpes Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Genital Herpes Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Genital Herpes Treatment by Countries (2017-2018)
Figure Middle East and Africa Genital Herpes Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Genital Herpes Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Genital Herpes Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Genital Herpes Treatment Growth Rate (2017-2018)
Figure Egypt Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Genital Herpes Treatment Growth Rate (2017-2018)
Figure Nigeria Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Genital Herpes Treatment Growth Rate (2017-2018)
Figure South Africa Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Genital Herpes Treatment Growth Rate (2017-2018)
Figure Turkey Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Genital Herpes Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table Dr. Reddy’s Laboratories Ltd. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mylan Pharmaceuticals Inc. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Teva Pharmaceuticals Inc. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis AG Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Hospira Inc. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sandoz Inc. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novopharm Ltd. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Apotheca Inc. Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline Genital Herpes Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Genital Herpes Treatment Market Share by Manufacturer
Figure Global Genital Herpes Treatment Revenue and Market Share by Manufacturer
Table Global Genital Herpes Treatment Price by Region (2017-2017)
Figure Top 5 Genital Herpes Treatment Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Genital Herpes Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Genital Herpes Treatment Market Forecast by Regions (2018-2025)
Figure North America Genital Herpes Treatment Market Forecast (2018-2025)
Figure United States Genital Herpes Treatment Market Forecast (2018-2025)
Figure Canada Genital Herpes Treatment Market Forecast (2018-2025)
Figure Mexico Genital Herpes Treatment Market Forecast (2018-2025)
Figure Europe Genital Herpes Treatment Market Forecast (2018-2025)
Figure Germany Genital Herpes Treatment Market Forecast (2018-2025)
Figure France Genital Herpes Treatment Market Forecast (2018-2025)
Figure UK Genital Herpes Treatment Market Forecast (2018-2025)
Figure Russia Genital Herpes Treatment Market Forecast (2018-2025)
Figure Italy Genital Herpes Treatment Market Forecast (2018-2025)
Figure Rest of Europe Genital Herpes Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Genital Herpes Treatment Market Forecast (2018-2025)
Figure China Genital Herpes Treatment Market Forecast (2018-2025)
Figure Japan Genital Herpes Treatment Market Forecast (2018-2025)
Figure Korea Genital Herpes Treatment Market Forecast (2018-2025)
Figure India Genital Herpes Treatment Market Forecast (2018-2025)
Figure Southeast Asia Genital Herpes Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Genital Herpes Treatment Market Forecast (2018-2025)
Figure South America Genital Herpes Treatment Market Forecast (2018-2025)
Figure Brazil Genital Herpes Treatment Market Forecast (2018-2025)
Figure Argentina Genital Herpes Treatment Market Forecast (2018-2025)
Figure Columbia Genital Herpes Treatment Market Forecast (2018-2025)
Figure Rest of South America Genital Herpes Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Genital Herpes Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Genital Herpes Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Genital Herpes Treatment Market Forecast (2018-2025)
Figure Egypt Genital Herpes Treatment Market Forecast (2018-2025)
Figure Nigeria Genital Herpes Treatment Market Forecast (2018-2025)
Figure South Africa Genital Herpes Treatment Market Forecast (2018-2025)
Figure Turkey Genital Herpes Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Genital Herpes Treatment Market Forecast (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Type (2018-2025)
Figure Global Genital Herpes Treatment Market Share Forecast by Type (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Type (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Indication (2018-2025)
Figure Global Genital Herpes Treatment Market Share Forecast by Indication (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Indication (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Route Of Administration (2018-2025)
Figure Global Genital Herpes Treatment Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Route Of Administration (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Distribution Channel (2018-2025)
Figure Global Genital Herpes Treatment Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Genital Herpes Treatment Forecast by Distribution Channel (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*